Anat Ashkenazi, 52, became chief financial officer of Alphabet in July, after serving as CFO at pharmaceutical company Eli Lilly for three years. At a tech conference earlier this month ...

Eli Lilly has called on financial regulators ... The issue was also alluded to by Lilly’s chief financial officer, Anat Ashkenazi, on the company’s fourth-quarter results call yesterday ...

today announced that Anat Ashkenazi, currently Executive Vice President and Chief Financial... Eli Lilly and Company (NYSE:LLY) announced today that Anat Ashkenazi has resigned as chief financial ...

As revenues for Eli Lilly’s popular weight loss drug Zepbound continue ... while interim CFO Gordon Brooks received $2.7 million. Anat Ashkenazi, who left the company to become CFO at Alphabet in July ...

INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY) announced today that Anat Ashkenazi has resigned from her position as Chief... San Francisco, June 5 (IANS) Google (NASDAQ:GOOGL) parent Alphabet ...

ByInvesting.com • Jun 05, 2024 Alphabet names Eli Lilly's Ashkenazi as its new CFO Alphabet (NASDAQ:GOOGL) has appointed Anat Ashkenazi as its new chief financial officer (CFO), bringing on board a ...

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) had a banner year in 2024. The company's sales surged 32% to over $45 billion on massive growth from its GLP-1 agonist products, Mounjaro for ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets, valued at more than $100 billion. Each of them has advantages, as well as dark spots in the pipeline of ...

Meanwhile, pharma company Eli Lilly (NYSE: LLY) offers a much lower yield of less than 1%, but its dividend growth rate has been far more impressive. Which stock is the better buy if your priority ...

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical company’s weight-loss drug. Hours after Hims & Hers posted a blog ...